Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Operating Expenses (2022 - 2025)

Bioregenx's Operating Expenses history spans 4 years, with the latest figure at $1.3 million for Q4 2025.

  • Quarterly results put Operating Expenses at $1.3 million for Q4 2025, down 93.27% from a year ago — trailing twelve months through Dec 2025 was $2.7 million (down 88.75% YoY), and the annual figure for FY2025 was $2.7 million, down 88.75%.
  • Operating Expenses for Q4 2025 was $1.3 million at Bioregenx, up from $434856.0 in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $18.6 million in Q4 2024 to a low of $13474.0 in Q3 2022.
  • The 4-year median for Operating Expenses is $703800.5 (2024), against an average of $2.1 million.
  • The sharpest move saw Operating Expenses soared 22460.15% in 2023, then tumbled 93.27% in 2025.
  • Year by year, Operating Expenses stood at $14449.0 in 2022, then soared by 3980.42% to $589580.0 in 2023, then skyrocketed by 3061.5% to $18.6 million in 2024, then tumbled by 93.27% to $1.3 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $1.3 million, $434856.0, and $459715.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.